Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)

Michael Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J Bahlis, Joaquin Martinez-Lopez, Guenther Koehne, Paula Rodriguez Otero, H. Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T Sullivan, Alexander Lesokhin

Blood (2023) 142 (Supplement 1): 3385.

https://doi.org/10.1182/blood-2023-182130

Published: 2023

Journal Articles

Clinical Factors Associated with Cytokine Release Syndrome and Dosing Recommendations for Restarting Elranatamab Following an Interruption

Ruben Niesvizky, Bertrand Arnulf, Mohamad Mohty, Ajay K. Nooka, Salomon Manier, Michael Tomasson, Nizar J Bahlis, Donald Irby, Jennifer Hibma, Andrea Viqueira, Eric Leip, Alexander Lesokhin

Blood (2023) 142 (Supplement 1): 3384.

https://doi.org/10.1182/blood-2023-182166

Published: 2023

Journal Articles

Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience

Kalyan Nadiminti, MD, Christopher Strouse, MD, Praveen Vikas, MD, Lindsay Dozeman, Allyson Schultz, Sarah L Mott, Jillna Claus, Umar Farooq, MD, Margarida Silverman, MD, Michael Tomasson, MD, Fenghuang Zhan, MD PhD, Yogesh Jethava, MBBS, MDFRCPath, MRCP, Guido J. Tricot, MD PhD

Blood (2018) 132 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2018-99-113890

Published: 2018

Journal Articles

A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)

Kalyan Nadiminti, MD, Christopher Strouse, MD, Praveen Vikas, MD, Lindsay Dozeman, Allyson Schultz, Gabrielle Berns, Jillna Claus, Sarah L Mott, Umar Farooq, MD, Margarida Silverman, MD, Michael Tomasson, MD, Fenghuang Zhan, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP

Blood (2018) 132 (Supplement 1): 2153.

https://doi.org/10.1182/blood-2018-99-118443

Published: 2018

Journal Articles

A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma in Persons of African Ancestry [African-American Multiple Myeloma Study (AAMMS)] Identifies Suggestive Risk Variants

Zhaohui Du, M.S., Niels Weinhold, PhD, David Van Den Berg, PhD, Amie Hwang, PhD MPH, Xin Sheng, M.S., Victor Hom, M.S., Sikander Ailawadhi, Ajay K. Nooka, MDMPH, Seema Singhal, MD, Karen Pawlish, Sc.D, M.P.H, Edward S. Peters, DMD, SM, SM, ScD, Cathryn Bock, PhD, Ann Mohrbacher, MD, Alexander Stram, M.S., Donglei Hu, M.S., John Graff, PhD, M.S., Sonja I Berndt, PhD, William J. Blot, PhD, John David Carpten, PhD, Graham Casey, PhD, Victoria L. Stevens, PhD, Rick Kittles, PhD, Goodman Phyllis, M.S., Anselm Hennis, MB;BS, MSc., PhD DLSHTM, FRCP, FACP, Eric A. Klein, MD, Barbara Nemesure, Benjamin A. Rybicki, Janet Stanford, John Witte, PhD, Christine B. Ambrosone, Esther M. John, Leslie Bernstein, PhD, M.S., Antoinette Stroup, PhD, Andrew Olshan, Wei Zheng, MD PhD, Jennifer J. Hu, Regina Ziegler, PhD, M.P.H., Sarah J. Nyante, Elisa Bandera, Sue Ann Ingles, PhD, Jayesh Mehta, MD, Graham A Colditz, MD DrPH, Michael Tomasson, MD, Mark A. Fiala, BS, Howard Terebelo, DO, Nalini Janakiraman, MD, Laurence Kolonel, MD, PhD, Loic Le Marchand, MD, PhD, Kenneth C Anderson, MD, Elad Ziv, MD, Brian C.-H. Chiu, PhD, David Conti, PhD, Daniel Stram, PhD, Ravi Vij, MDMBA, Leon Bernal-Mizrachi, MD, Jeffrey A Zonder, MD, Gareth J. Morgan, MD PhD, Carol Ann Huff, MD, Robert Z. Orlowski, MD PhD, Sagar Lonial, MD, Christopher A. Haiman, PhD, Wendy Cozen, DO,MPH

Blood (2017) 130 (Supplement 1): 3058.

https://doi.org/10.1182/blood.V130.Suppl_1.3058.3058

Published: 2017

Journal Articles

Variations in Multiple Myeloma Disease Presentation By Race

Mark A Fiala, BS, CCRP, Tanya M Wildes, MD MSCI, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA

Blood (2015) 126 (23): 5618.

https://doi.org/10.1182/blood.V126.23.5618.5618

Published: 2015

Journal Articles

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

Jesse Keller, MD, Mark A Fiala, BS, CCRP, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 3307.

https://doi.org/10.1182/blood.V126.23.3307.3307

Published: 2015

Journal Articles

The Association Between Performance Status and Health-Related Quality of Life

Mark A Fiala, BS, CCRP, Jesse Keller, MD, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA, Tanya M Wildes, MD MSCI

Blood (2015) 126 (23): 3312.

https://doi.org/10.1182/blood.V126.23.3312.3312

Published: 2015

Journal Articles

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

Mark A Fiala, BS, CCRP, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 2115.

https://doi.org/10.1182/blood.V126.23.2115.2115

Published: 2015

Journal Articles

A Second Generation, Multiple Myeloma-Specific, Targeted Sequencing Platform for Detecting Translocations, Copy Number Alterations, and Single Nucleotide Variants

Brian S White, PhD, Irena Lanc, PhD, Daniel Auclair, PhD, Robert Fulton, PhD, Mark A Fiala, BS, CCRP, Justin King, Gregory Ahmann, BS, Mary Derome, MS, Elaine R Mardis, PhD, Joan Levy, PhD, Ravi Vij, MD MBA, John F. DiPersio, MD PhD, Michael Tomasson, MD

Blood (2015) 126 (23): 4207.

https://doi.org/10.1182/blood.V126.23.4207.4207

Published: 2015

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

Journal Articles

Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees

Nicola J Camp, PhD, Rosalie G Waller, BS, Cassandra Garner, BS, Guido J Tricot, MD PhD, Michael Tomasson, MD, Djordje Atanackovic, MD, Martha Glenn, MD

Blood (2015) 126 (23): 1449.

https://doi.org/10.1182/blood.V126.23.1449.1449

Published: 2015

Journal Articles

The Senescence-Associated Secretory Phenotype In Multiple Myeloma

Tanya M Wildes, MD, MSCI, Jacob Paasch, BS, Mark A. Fiala, BS, CCRP, Ling Chen, PhD, Ravi Vij, MD, Keith E. Stockerl-Goldstein, MD, Sheila Stewart, PhD, Graham A. Colditz, MD, DrPH, Michael Tomasson, MD

Blood (2013) 122 (21): 5357.

https://doi.org/10.1182/blood.V122.21.5357.5357

Published: 2013

Journal Articles

Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice

Chelsea D. Mullins, BSci, Michael Tomasson, MD, Lan Lu, MSci, Mack Y. Su, Vishwanathan Hutchagowder, PhD, Ravi Vij, MBBS, MD, Shashikant Kulkarni, PhD, Liang Chu, PhD

Blood (2010) 116 (21): 137.

https://doi.org/10.1182/blood.V116.21.137.137

Published: 2010

Journal Articles

MCL1 Haploinsufficiency Protects Mice From MYC-Induced Acute Myeloid Leukemia.

Zhifu Xiang, MD, PhD, Hui Luo, PhD, Jacqueline E. Payton, MD, PhD, Lukas D Wartman, MD, Julie Ritchey, John F. DiPersio, MD, PhD, Timothy J. Ley, MD, Joseph T Opferman, PhD, Michael Tomasson, MD

Blood (2009) 114 (22): 764.

https://doi.org/10.1182/blood.V114.22.764.764

Published: 2009

Journal Articles

DNA Sequencing of a Murine Acute Promyelocytic Leukemia (APL) Genome Using Next Generation Technology.

Lukas D. Wartman, MD, Li Ding, David E. Larson, Michael D. McLellan, Heather Schmidt, Zhifu Xiang, MD, PhD, Michael Tomasson, MD, Elaine Mardis, PhD, Richard K. Wilson, PhD, Timothy J. Ley, MD

Blood (2009) 114 (22): 3965.

https://doi.org/10.1182/blood.V114.22.3965.3965

Published: 2009

Journal Articles

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Tom Fong, MD, Kim Trinkaus, PhD, Douglas R. Adkins, MD, Ravi Vij, MD, Steven Devine, MD, Michael Tomasson, MD, Lawrence T. Goodnough, MD, Timothy Graubert, MD, Shalini Shenoy, MD, John F. DiPersio, MD, PhD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 1800.

https://doi.org/10.1182/blood.V106.11.1800.1800

Published: 2005

Journal Articles

Mutations Required for Lymphoid Leukemogenesis Are Not Required for c-Myc to Rapidly Induce Acute Myeloid Leukemia.

Qing Li, MD., Ph.D, Hui Luo, MD, Julie O’Neal, Friederike Kreisel, Daisuke Inoyama, MD, Michelle M. Le Beau, MD, Michael Tomasson, MD

Blood (2004) 104 (11): 483.

https://doi.org/10.1182/blood.V104.11.483.483

Published: 2004

NARROW

Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical Factors Associated with Cytokine Release Syndrome and Dosing Recommendations for Restarting Elranatamab Following an Interruption

Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience

A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)

A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma in Persons of African Ancestry [African-American Multiple Myeloma Study (AAMMS)] Identifies Suggestive Risk Variants

Variations in Multiple Myeloma Disease Presentation By Race

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

The Association Between Performance Status and Health-Related Quality of Life

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

A Second Generation, Multiple Myeloma-Specific, Targeted Sequencing Platform for Detecting Translocations, Copy Number Alterations, and Single Nucleotide Variants

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees

The Senescence-Associated Secretory Phenotype In Multiple Myeloma

Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice

MCL1 Haploinsufficiency Protects Mice From MYC-Induced Acute Myeloid Leukemia.

DNA Sequencing of a Murine Acute Promyelocytic Leukemia (APL) Genome Using Next Generation Technology.

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Mutations Required for Lymphoid Leukemogenesis Are Not Required for c-Myc to Rapidly Induce Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only